Shanghai Medicilon Inc.(688202) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Zhitong FinanceMar 16 21:18 ET
Shanghai Medicilon Inc. (688202.SH): Has not yet repurchased company shares.
Gelonghui, February 28丨Shanghai Medicilon Inc. (688202.SH) announced that as of February 28, 2025, the company has not yet repurchased its shares through the centralized bidding trading method via the Shanghai Stock Exchange system.
Gelonghui FinanceFeb 28 05:06 ET
Medici: Medici: 2024 Annual Results Report Announcement
SZSIFeb 27 11:00 ET · Announcements
Medici: 2024 Annual Results Report Announcement
SZSIFeb 27 11:00 ET · Announcements
Shanghai Medicilon Inc. (688202.SH): Net loss of 0.316 billion yuan for the year 2024.
Shanghai Medicilon Inc. (688202.SH) released its performance report for the year 2024, during the reporting period the company achieved revenue of 10...
Zhitong FinanceFeb 27 07:18 ET
Revenues Not Telling The Story For Shanghai Medicilon Inc. (SHSE:688202) After Shares Rise 32%
Simply Wall StFeb 25 01:22 ET

Comments

Moomoo AI

Mar 6, 2024 07:34

Shanghai Medicilon's conservative liability management and light debt load are overshadowed by its loss-making status and shrinking revenue. Despite this, its balance sheet doesn't seem overly risky currently, but may need more capital if break-even isn't reached soon.

Is Shanghai Medicilon (SHSE:688202) Using Too Much Debt?

Spinee

Jan 29, 2024 09:47

A bill to prohibit contracting with certain biotechnology providers, and for other purposes.

BGI, MGI, Complete Genomics, Wuxi Apptec, and any subsidiary are included.
Last Friday, WuXi AppTec's shares tumble by 20% in Hong Kong and fall by a 10% limit-down in mainland China.
Other CRO stocks including Medicilon are also falling.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $BGI Genomics (300676.SZ)$ $MGI Tech Co., Ltd. (688114.SH)$ $Shanghai Medicilon Inc. (688202.SH)$ $Novo-Nordisk A/S (NVO.US)$ $Hang Seng H-Share Index ETF (02828.HK)$

2

Moomoo AI

Jan 2, 2024 12:57

Analysts express skepticism despite investors expecting the company to reverse its trend and outperform. The unsustainable level of earnings growth may depress the stock price according to them.

Shanghai Medicilon Inc. (SHSE:688202) Investors Are Less Pessimistic Than Expected

slicric33

Feb 13, 2021 11:30

$Shanghai Medicilon Inc. (688202.SH)$ nice

1

688202 Shanghai Medicilon Inc.

Trade Overview

Capital Trend

News

Comments

Market Insights